© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
June 23, 2021
The FDA approved Pradaxa (dabigatran etexilate) to treat venous thromboembolism in children aged 3 months to less than 12 years.
June 01, 2020
Researchers from the Mount Sinai COVID Informatics Center report improved survival rates in COVID patients treated with anticoagulants.
January 27, 2020
Administration time for warfarin did not affect the stability of the drug’s anticoagulation effect, a new study showed.
November 15, 2019
First and currently only biological targeting P-selectin.
October 09, 2019
Also indciated to control bleeding and perioperative management.
July 29, 2019
Black box warns of increased risk of blood clots and death.
June 14, 2019
Study finds higher Ischemic events and mortality in transcatheter valve replacement patients taking non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists.
Low-risk atrial fibrillation patients who take oral anticoagulants have a lower risk of dementia than those who do not, a study says.
May 24, 2019
The use of direct‐acting oral anticoagulants has increased among nursing home residents with atrial fibrillation.
Overestimating the bleeding risk of anticoagulants may lead to poor compliance.